Eugen Feist

9.2k total citations
202 papers, 5.7k citations indexed

About

Eugen Feist is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Eugen Feist has authored 202 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Rheumatology, 69 papers in Immunology and 65 papers in Hematology. Recurrent topics in Eugen Feist's work include Rheumatoid Arthritis Research and Therapies (76 papers), Autoimmune and Inflammatory Disorders Research (60 papers) and Systemic Lupus Erythematosus Research (43 papers). Eugen Feist is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (76 papers), Autoimmune and Inflammatory Disorders Research (60 papers) and Systemic Lupus Erythematosus Research (43 papers). Eugen Feist collaborates with scholars based in Germany, United States and Switzerland. Eugen Feist's co-authors include Gerd R Burmester, Thomas Dörner, Karl Egerer, Gerd‐Rüdiger Burmester, Bruno Fautrel, Falk Hiepe, G.-R. Burmester, Arne Hansen, Annett M. Jacobi and Marcus Odendahl and has published in prestigious journals such as New England Journal of Medicine, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Eugen Feist

184 papers receiving 5.5k citations

Peers

Countries citing papers authored by Eugen Feist

Since Specialization

Citations

This map shows the geographic impact of Eugen Feist's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eugen Feist with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eugen Feist more than expected).

Fields of papers citing papers by Eugen Feist

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eugen Feist. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eugen Feist. The network helps show where Eugen Feist may publish in the future.

Co-authorship network of co-authors of Eugen Feist

This figure shows the co-authorship network connecting the top 25 collaborators of Eugen Feist. A scholar is included among the top collaborators of Eugen Feist based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eugen Feist. Eugen Feist is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Current evidence on switching between biologic therapies for Still’s disease: A systematic literature review 2025 ·Seminars in Arthritis and Rheumatism ·Lorenzo Dagna, Eugen Feist, (unknown), Andreas Clemens, (unknown), (unknown)	0
2	PD1+ innate lymphoid cells 3 predict JAK-dependent inflammation in rheumatoid arthritis 2025 ·Journal of Autoimmunity ·(unknown), (unknown), (unknown), Carolyn E. Behrendt, Ildikò Rita Dunay, Thomas Häupl, Eugen Feist, Monika C. Brunner‐Weinzierl	0
3	Association Between Patient-Reported Pain and Remission or Low Disease Activity in Patients with Rheumatoid Arthritis: Data from RA-BE-REAL Prospective Observational Study 2024 ·Rheumatology and Therapy ·Peter C. Taylor, (unknown), (unknown), Ewa Haładyj, Inmaculada de la Torre, Bruno Fautrel, Rieke Alten, Peter Nash, Eugen Feist	1
4	Olokizumab plus methotrexate: safety and efficacy over 106 weeks of treatment 2024 ·Annals of the Rheumatic Diseases ·Eugen Feist, Roy Fleischmann, Saeed Fatenejad, (unknown), (unknown), (unknown), Michael E. Luggen, (unknown), Samsonov MIu, Josef S Smolen	3
5	Implementation of the new DGRh S2e guideline on diagnostics and treatment of adult-onset Still’s disease in Germany 2024 ·Zeitschrift für Rheumatologie ·R Friedrich, Anna Kernder, Norbert Blank, Diana Ernst, Jörg Henes, Gernot Keyßer, Philipp Klemm, Martin Krusche, (unknown), Jürgen Rech, (unknown), (unknown), Stefan Vordenbäumen, Eugen Feist	1
6	Etanercept in Axial Spondyloarthritis, Psoriatic Arthritis, and Plaque Psoriasis: Real-World Outcome Data from German Non-interventional Study ADEQUATE 2024 ·Rheumatology and Therapy ·Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaçi, (unknown), Klaus Pietzner, (unknown)	0
7	Autoinflammatorische Syndrome 2023 ·Die Innere Medizin ·Hanna Bonnekoh, Martin Krusche, Eugen Feist, Annette D. Wagner, Anne Pankow	0
8	Autoinflammatorische Syndrome 2023 ·Zeitschrift für Rheumatologie ·Hanna Bonnekoh, Martin Krusche, Eugen Feist, Annette D. Wagner, Anne Pankow	1
9	Management of patients with rheumatoid arthritis in real clinical practice: Switching from interleukin 6 receptor inhibitors to interleukin 6 inhibitor (olokizumab) 2023 ·SHILAP Revista de lepidopterología ·А. А. Баранов, (unknown), (unknown), (unknown), Е. А. Богданова, (unknown), Е. П. Иливанова, (unknown), (unknown), (unknown), (unknown), O. B. Nesmeyanova, (unknown), P. А. Shesternya, (unknown), Eugen Feist, Е. Л. Насонов	2
10	Allgemeine Kenntnisse zu häufig angewandten Testverfahren in der rheumatologisch-immunologischen Diagnostik und Forschung 2023 ·Zeitschrift für Rheumatologie ·Dirk Reinhold, Annegret Reinhold, Burkhart Schraven, Eugen Feist	1
11	Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes 2022 ·Rheumatology and Therapy ·Eugen Feist, Xenofon Baraliakos, Frank Behrens, Diamant Thaçi, T. Klopsch, (unknown), (unknown), Klaus Pietzner, (unknown), Peter‐Andreas Löschmann	12
12	Effectiveness of Different Rituximab Doses Combined with Leflunomide in the Treatment or Retreatment of Rheumatoid Arthritis: Part 2 of a Randomized, Placebo-Controlled, Investigator-Initiated Clinical Trial (AMARA) 2022 ·Journal of Clinical Medicine ·(unknown), Ann Christina Foldenauer, (unknown), Rieke Alten, Martin Aringer, Marina Backhaus, Gerd R Burmester, Eugen Feist, Herbert Kellner, Klaus Krueger, Ulf Müller‐Ladner, Andrea Rubbert‐Roth, Hans‐Peter Tony, Siegfried Wassenberg, Harald Burkhardt, Frank Behrens	1
13	Tocilizumab for the Treatment of Familial Mediterranean Fever—A Randomized, Double-Blind, Placebo-Controlled Phase II Study 2022 ·Journal of Clinical Medicine ·Jörg Henes, Sebastian Saur, David M. Kofler, Claudia Kedor, Christoph Meisner, (unknown), Martin Krusche, (unknown), Theodoros Xenitidis, Hendrik Schulze‐Koops, Eugen Feist	12
14	Impact of Different JAK Inhibitors and Methotrexate on Lymphocyte Proliferation and DNA Damage 2021 ·Journal of Clinical Medicine ·(unknown), L D Voss, Karina Guttek, Dirk Roggenbuck, Eugen Feist, Dirk Reinhold	13
15	Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial 2020 ·Annals of the Rheumatic Diseases ·Claudia Kedor, Joachim Listing, Jan Zernicke, Anja Weiß, Frank Behrens, Norbert Blank, Jörg Henes, Joern Kekow, Andrea Rubbert‐Roth, Hendrik Schulze‐Koops, Eva Seipelt, Christof Specker, Eugen Feist	64
16	Autoantibodies against a novel citrullinated fibrinogen peptide related to smoking status, disease activity and therapeutic response to methotrexate in cuban patients with early rheumatoid arthritis 2020 ·Rheumatology International ·(unknown), Eugen Feist, (unknown), Hilda Garay, (unknown)	5
17	Carbamylation of vimentin is inducible by smoking and represents an independent autoantigen in rheumatoid arthritis 2017 ·Annals of the Rheumatic Diseases ·Caroline Ospelt, Holger Bang, Eugen Feist, Giovanni G. Camici, Stephan Sylvest Keller, J. Detert, (unknown), Steffen Gay, (unknown), Gerd R Burmester	59
18	New Assay Generation for Antibodies Against Modified and Citrullinated Peptides Predicts Poor Response to TNF Inhibitor Therapy 2011 ·Arthritis & Rheumatism ·Lotta Ljung, Karl Egerer, Holger Bang, Eugen Feist, Gerd R Burmester, Solbritt Rantapää‐Dahlqvist	1
19	Tissue‐specific up‐regulation of the proteasome subunit β5i (LMP7) in Sjögren's syndrome 2006 ·Arthritis & Rheumatism ·(unknown), Lorena Martinez‐Gamboa, Anja Dankof, Bruno Stuhlmüller, Thomas Dörner, Veit Krenn, Karl Egerer, Paul Rudolph, G.-R. Burmester, Eugen Feist	56
20	Disturbed Peripheral B Lymphocyte Homeostasis in Systemic Lupus Erythematosus 2000 ·The Journal of Immunology ·Marcus Odendahl, Annett M. Jacobi, Arne Hansen, Eugen Feist, Falk Hiepe, Gerd R Burmester, Peter E. Lipsky, Andreas Radbruch, Thomas Dörner	497

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact